Percutaneous Valve Technologies , Inc.

Percutaneous Valve Technologies (PVT) was founded in 1999 by Dr. Alain Cribier, Dr. Martin Leon, Mr. Stanley Rabinovich and Mr. Stanton Rowe. Percutaneous Valve Technologies, Inc. (PVT) located in Fort Lee, NJ, with a subsidiary in Israel, is a privately held medical technology company developing an innovative, percutaneous approach for delivering heart valves to treat late-stage aortic stenosis. This less invasive device, designed by PVT, is a proprietary blend of balloon-expandable stent technology integrated with a bioprosthetic valve. The procedure deploys the stent across the old valve, holding it permanently open allowing for replacement of the old stenotic valve with a new one, thus removal of the failing valve is not required. It is designed to be delivered in a cardiac catheterization laboratory under local anesthesia, using fluoroscopic guidance, thereby avoiding general anesthesia and highly invasive open-heart surgery techniques currently used in valve replacement. The Board of Directors of PVT includes: Stanton Rowe, President & CEO Stanley Rabinovich, Executive Vice President & COO Abi Zakai, CEO, Aran Research and Development Ltd, Caesarea, Israel Jeff Barnes, General Partner, Oxford Bioscience Partners, Boston, MA Yuval Binur, Ph.D., General Partner, Medica Venture Partners, Herzelia, Israel Marv Woodall, former Divisional President, Johnson & Johnson Steve Oesterle, MD, Senior Vice President for Medicine and Technology, Medtronic, Inc Paul LaViolette, Senior Vice President & Group President, Cardiovascular, Boston Scientific Corporation The Scientific Advisory Board of PVT includes: Martin Leon, MD, Lenox Hill Hospital, New York, NY Alain Cribier, MD, University Hospital, Rouen, France Bill O'Neill, MD, William Beaumont Hospital, Royal Oaks, MI Jeff Moses, MD, Lenox Hill Hospital, New York, NY Donald Baim, MD, Harvard Medical School, Boston, MA Mehmet Oz, MD, Columbia University Hospital, New York, NY Antonio Colombo, MD, Centro Cuore Columbus, Milan, Italy Patrick Serruys, MD, Ph.D., Erasmus University, Rotterdam, The Netherlands Ted Feldman, MD, Evanston Hospital, Chicago, IL